Publication | Closed Access

Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study

Metastatic Breast CancerOncologyBreast OncologyPharmacologyBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentMedicineSafety ProfileWeekly Carboplatin